The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer.
Stephan B DreyerSarah RaeKirsty BissetRosie Upstill-GoddardGeorgios GemenetzisAmber L JohnsEuan J DicksonAnubhav MittalAnthony J GillFraser DuthieAntonio PeaRita T LawlorAldo ScarpaRoberto SalviaAlessandra PulvirentiAlessandro ZerbiFederica MarchesiColin J McKayAndrew V BiankinJaswinder S SamraDavid K ChangNigel B Jamiesonnull nullnull nullPublished in: Annals of surgery (2023)
Aggressive tumor biology as measured by molecular subtype predicts poor outcome following pancreatectomy for PDAC and should be utilized to inform patient selection for surgery.